These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 28983659)
1. Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy. Koike H; Nakamura T; Hashizume A; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G J Neurol; 2017 Nov; 264(11):2293-2302. PubMed ID: 28983659 [TBL] [Abstract][Full Text] [Related]
2. Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis. Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G Intern Med; 2018 Dec; 57(23):3365-3370. PubMed ID: 29984770 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area. Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417 [TBL] [Abstract][Full Text] [Related]
4. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan. Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406 [TBL] [Abstract][Full Text] [Related]
5. Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation. Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):13-14. PubMed ID: 31343285 [No Abstract] [Full Text] [Related]
6. Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation. Nakamura T; Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):6. PubMed ID: 31343341 [No Abstract] [Full Text] [Related]
7. Progression of myocardial sympathetic denervation assessed by Azevedo Coutinho MDC; Cortez-Dias N; Cantinho G; Conceição I; Guimarães T; Lima da Silva G; Nobre Menezes M; Francisco AR; Plácido R; Pinto FJ Rev Port Cardiol; 2017 May; 36(5):333-340. PubMed ID: 28479268 [TBL] [Abstract][Full Text] [Related]
8. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231 [TBL] [Abstract][Full Text] [Related]
10. A case of familial amyloid polyneuropathy homozygous for the transthyretin Val30Met gene with motor-dominant sensorimotor polyneuropathy and unusual sural nerve pathological findings. Yoshioka A; Yamaya Y; Saiki S; Hirose G; Shimazaki K; Nakamura M; Ando Y Arch Neurol; 2001 Nov; 58(11):1914-8. PubMed ID: 11709003 [TBL] [Abstract][Full Text] [Related]
11. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. Koike H; Tanaka F; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Fujitake J; Kawanami T; Kato T; Yamamoto M; Sobue G J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):152-8. PubMed ID: 22228785 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan. Sobue G; Koike H; Misu K; Hattori N; Yamamoto M; Ikeda S; Ando Y; Nakazato M; Inukai A Amyloid; 2003 Aug; 10 Suppl 1():32-8. PubMed ID: 14640040 [TBL] [Abstract][Full Text] [Related]
13. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Coutinho MC; Cortez-Dias N; Cantinho G; Conceição I; Oliveira A; Bordalo e Sá A; Gonçalves S; Almeida AG; de Carvalho M; Diogo AN Circ Cardiovasc Imaging; 2013 Sep; 6(5):627-36. PubMed ID: 23833285 [TBL] [Abstract][Full Text] [Related]
14. The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study. Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sakurai T; Shimohata T; Katsuno M; Sobue G J Neurol Sci; 2018 Nov; 394():99-106. PubMed ID: 30243104 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus. Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945 [TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482 [TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54. Nagasaka T; Togashi S; Watanabe H; Iida H; Nagasaka K; Nakamura Y; Miwa M; Kobayashi F; Shindo K; Shiozawa Z J Neurol Sci; 2009 Jan; 276(1-2):88-94. PubMed ID: 18930252 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286 [TBL] [Abstract][Full Text] [Related]
19. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096 [TBL] [Abstract][Full Text] [Related]